Concepedia

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

Jonathan M. Meyer, Vicki G. Davis, Donald Goff, Joseph P. McEvoy, Henry A. Nasrallah, Sonia M. Davis, Robert A. Rosenheck, Gail L. Daumit, John Hsiao, Marvin S. Swartz,

Schizophrenia Research · 2008 · 287 citations · 38 references

DOIFull text

Open access

Concepts

References

38

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study

Ömer Toprak, Hüseyin Kurt, Yasin Sarı et al. · Kidney & Blood Pressure Research · 2017 · 29.7K citations · Full text

, , +17

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Scott M. Grundy · JAMA · 1993 · 27.9K citations

, , +12

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Evaluation Expert Panel on Detection · JAMA · 2001 · 26K citations

, , +10

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy et al. · New England Journal of Medicine · 2005 · 5.9K citations · Full text

, , +14

C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events

Paul M. Ridker, Julie E. Buring, Nancy R. Cook et al. · Circulation · 2003 · 2.3K citations

, , +15